Jefferies Financial Group Inc. Vertex Pharmaceuticals Inc Put Options Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $1.72 Million - $2.05 Million	5,000 Added 128.21%	8,900 $3.62 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $1.22 Million - $1.3 Million	3,600 Added 1200.0%	3,900 $1.36 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $6.19 Million - $6.93 Million	-19,700 Reduced 98.5%	300 $105,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $56,646 - $64,620	-200 Reduced 0.99%	20,000 $6.3 Million
Q4 2022 Sep 21, 2023	BUY	$285.76 - $321.48 $5.69 Million - $6.4 Million	19,900 Added 6633.33%	20,200 $5.83 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $5.77 Million - $6.49 Million	20,200 New	20,200 $5.83 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.